Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 9 (3) , 126-132
- https://doi.org/10.1016/s1471-4914(03)00020-0
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?Neuroscience Letters, 2002
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Cell death mechanisms in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophyNeuroscience Letters, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Diverse Mutations in the Gene for Cartilage Oligomeric Matrix Protein in the Pseudoachondroplasia–Multiple Epiphyseal Dysplasia Disease SpectrumAmerican Journal of Human Genetics, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Midbrain development induced by FGF8 in the chick embryoNature, 1996
- Similar Inhibition of Mitochondrial Respiration by 1-Methyl-4-Phenyl-Pyridinium (MPP+) and by a Unique N-Methylated Beta-Carboline Analogue, 2,9?Dimethyl?Norharman (2,9Me2NH)Annals of the New York Academy of Sciences, 1992